Document details

Anti-leishmanial ige antibodies: a marker of active disease in visceral leishmaniasis


Description

p. 426–430

Submitted by Santiago Fabio (fabio.ssantiago@hotmail.com) on 2013-08-20T19:04:15Z No. of bitstreams: 1 4444444444444444444444.pdf: 81049 bytes, checksum: 80b46900692f3f8459a653c83f5aca3e (MD5)

Approved for entry into archive by Alda Lima da Silva(sivalda@ufba.br) on 2013-08-23T21:54:32Z (GMT) No. of bitstreams: 1 4444444444444444444444.pdf: 81049 bytes, checksum: 80b46900692f3f8459a653c83f5aca3e (MD5)

Made available in DSpace on 2013-08-23T21:54:32Z (GMT). No. of bitstreams: 1 4444444444444444444444.pdf: 81049 bytes, checksum: 80b46900692f3f8459a653c83f5aca3e (MD5) Previous issue date: 1998

Abstract. Visceral leishmaniasis (VL) is characterized by a depression of the T helper cell type 1 immune response. Although mRNA expression for interleukin-4 (IL-4) is observed, evidence of the role of this cytokine in the pathogenesis of VL has been lacking. Since IL-4 is involved in IgE synthesis, we measured the total IgE and Leishmania antigen-specific IgE antibody levels in sera from patients with VL. Specific IgE antibodies detected by an ELISA technique after absorbing the sera with purified sheep IgG anti-human IgG were found in all 23 patients with VL and were not detected in subjects with subclinical Leishmania chagasi infection (n 5 10), Chagas’ disease (n 5 10), atopic patients (n 5 10), and healthy controls (n 5 10). Levels of Leishmania-specific IgE (optical density values) before and after treatment were 0.100 6 0.03 (mean 6 SD) and 0.028 6 0.002, respectively (P , 0.05). These results indicate that a specific IgE response is useful in the diagnosis of active disease and to evaluate response to treatment.

Salvador

Document Type Journal article
Language English
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents